Filing Details

Accession Number:
0001437749-16-043049
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-07 17:11:21
Reporting Period:
2016-12-05
Filing Date:
2016-12-07
Accepted Time:
2016-12-07 17:11:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1586049 Oxford Immunotec Global Plc OXFD In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592286 Peter Wrighton-Smith C/O Oxford Immunotec Global Plc
94C Innovation Drive
Abingdon, Oxfordshire X0 OX14 4RZ
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-12-05 1,140 $0.81 444,454 No 4 M Direct
Ordinary Shares Disposition 2016-12-05 1,140 $15.00 443,314 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2016-12-05 1,140 $0.00 1,140 $0.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
108,490 2020-02-17 No 4 M Direct
Footnotes
  1. The original exercise price of these options was priced in GBP at GBP0.51 and converted to US$ at an exchange rate of US$1.58823=1GBP.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
  3. Exercise from an option granted February 28, 2013, which became fully vested on April 1, 2014.